Skip to main content

Month: November 2024

Rakovina Therapeutics Announces 2024 Q3 Financial Results and Provides Corporate Update

All dollar amounts reflected in Canadian dollars unless otherwise stated VANCOUVER, British Columbia, Nov. 29, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for the third quarter ending September 30, 2024 and provides an update to corporate activities. “I couldn’t be more proud of the Rakovina Therapeutics team and the remarkable progress we’ve made together in 2024,” said Executive Chairman Jeffrey Bacha. “Artificial intelligence is no longer just the future of drug development—it’s the reality we’re building today. We are privileged to have world-class experts driving the integration of cutting-edge AI with our laboratory infrastructure at the...

Continue reading

Icona Capital Acquires Cromwell’s European Platform via Stoneweg, Doubles Real Estate Aum to €8 Billion

LONDON, Nov. 29, 2024 (GLOBE NEWSWIRE) — Icona Capital, a leading alternative investment company, has entered into a binding agreement with Cromwell Property Group to acquire their European fund management platform and associated co-investments via Stoneweg, a real estate manager, which totals up to €3.9 billion of real estate assets under management, for a total consideration of €280 million, this includes:100% interest in Cromwell Europe Limited 27.8% unitholding in CEREIT, a real estate investment trust listed in Singapore with a €2.2 billion portfolio 100% interest in the Singapore-based Manager of CEREIT 50% interest in the Cromwell Urban Italy Logistics FundThe enlarged group led by Icona’s founder and current CEO, Max-Hervé George (Stoneweg Strategic Shareholder), Stoneweg’s co-founders, Jaume Sabater (CEO) and Joaquin...

Continue reading

O2Gold Provides Additional Update on Quebec Aur Transaction

TORONTO, Nov. 29, 2024 (GLOBE NEWSWIRE) — O2Gold Inc. (NEX: OTGO.H) (“O2Gold” or the “Company”) is pleased to provide an additional update on its pending acquisition of a gold mining exploration property in Quebec through the purchase of all of the issued and outstanding shares of Quebec Aur Ltd. (the “Target”) pursuant to a share exchange agreement entered into by the Company with the Target and its shareholders dated April 15, 2024, as amended November 14, 2024 (the “Acquisition”). Today, the Company received an extension from the TSX Venture Exchange to close its previously announced non-brokered private placement financing of 15 million subscription receipts and 15 million flow-through subscription receipts for aggregate gross proceeds to the Company of $1.5 million (the “Offering”). The Company now has until January 6, 2025,...

Continue reading

Brazil Potash Announces Closing of Initial Public Offering

MANAUS, Brazil, Nov. 29, 2024 (GLOBE NEWSWIRE) — Brazil Potash Corp. (“Brazil Potash” or the “Company”) announced today the closing of its initial public offering (the “IPO”) of 2,000,000 of its common shares, no par value per share (“Common Shares”), at a price to the public of US$15.00 per share. The gross proceeds to the Company from the IPO, before deducting underwriting discounts and commissions and estimated offering expenses payable by the Company, were US$30.0 million. In addition, the Company has granted the underwriters an option to purchase up to an additional 300,000 Common Shares, for a period of 30 days from the date of the final prospectus, to cover over-allotments, if any. The Common Shares commenced trading on the NYSE American on November 27, 2024 under the symbol “GRO”. Brazil Potash intends to use the net proceeds...

Continue reading

Fluent, Inc. Announces $5.75 Million Registered Direct Offering and $2.75 Million Concurrent Private Offering

NEW YORK, Nov. 29, 2024 (GLOBE NEWSWIRE) — Fluent, Inc. (NASDAQ: FLNT) (“Fluent”), a leader in performance marketing, today announced that it has entered into a definitive agreement for the purchase and sale of 2,483,586 shares of its common stock at a purchase price of $2.3152 per share of common stock in a registered direct offering (the “Registered Direct Offering”). In addition, in a concurrent private placement, Fluent will issue unregistered pre-funded warrants to purchase up to 1,187,802 shares of its common stock at a purchase price of $2.3147 per unregistered pre-funded warrant (the “Concurrent Private Placement,” together with the Registered Direct Offering, the “Offerings”). The exercisability of the pre-funded warrants will be subject to stockholder approval. If such stockholder approval is obtained, the pre-funded...

Continue reading

Anoto publishes prospectus

Anoto Group AB (the “Company” or “Anoto”) today publishes a prospectus (“the Prospectus”). The Prospectus has been prepared in connection with (i) the admission to trading of 125,043,750 common shares in Anoto which the board of directors decided to issue on October 25, 2024, subject to subsequent approval by an extraordinary general meeting, (ii) the admission to trading of 230,636,111 common shares that have been issued through a set-off issue which Anoto’s board of directors decided on October 25, 2024, subject to subsequent approval by an extraordinary general meeting, due to the convertible investment agreement the Company entered into on June 27, 2024, (iii) the invitation to subscribe for shares in the Company which Anoto’s board of directors decided to offer on October 25, 2024, subject to subsequent approval...

Continue reading

Patagonia Gold Third Quarter 2024 Financial Results

VANCOUVER, British Columbia, Nov. 29, 2024 (GLOBE NEWSWIRE) — Patagonia Gold Corp. (“Patagonia” or the “Company”) (TSXV: PGDC) announces its financial results for the quarter ended September 30, 2024 (“Q3 2024”). The financial statements together with the related management’s discussion and analysis are available on the Company’s website and under the Company’s profile on SEDAR+ at www.sedarplus.ca. HighlightsGenerated revenue of US$2.4 million in Q3 2024. Produced 796 gold equivalent ounces(1) and sold 955 gold equivalent ounces(1) in Q3 2024. On November 6th, the Company received the final permit to advance with the construction and development of the Calcatreu project. Incurred exploration expenditures of US$0.9 million in Q3 2024. On October 9th, the Company entered into a definitive agreement with Compañía Inversora de Minas...

Continue reading

Brookfield Infrastructure Completes 30-Year Subordinated Note Offering

All amounts in U.S. dollars BROOKFIELD, News, Nov. 29, 2024 (GLOBE NEWSWIRE) — Brookfield Infrastructure Partners L.P. (NYSE: BIP; TSX: BIP.UN) (“Brookfield Infrastructure”) today announced the closing of a public offering of $300 million of Fixed-to-Fixed Reset Rate Subordinated Notes due March 15, 2055 (the “notes”). The notes will bear interest at an annual rate of 6.750% until March 15, 2030 and thereafter will be reset every five years at an annual rate equal to the five-year U.S. treasury rate, plus a spread of 2.453%; provided, that the interest rate during any five-year interest period will not reset below 6.750%. Brookfield Infrastructure intends to use the net proceeds of the offering to refinance existing indebtedness and for general corporate purposes. The notes were issued by Brookfield Infrastructure Finance ULC,...

Continue reading

TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split

BOSTON, Nov. 29, 2024 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today announced that its Board of Directors has approved an effective time at 12:01 a.m. Eastern Standard Time December 4, 2024, for its 1-for-33 reverse stock split. TransCode’s common stock is expected to begin trading on a split-adjusted basis on the Nasdaq Capital Market on December 4, 2024, under the current trading symbol, “RNAZ.” The reverse stock split was approved by TransCode’s stockholders and Board of Directors on November 22, 2024, and is intended to increase the per share trading price of the Company’s common stock to enable the Company to meet the minimum bid price requirement for continued...

Continue reading

Sirios Resources Announces Private Placements

Not for distribution to United States newswire services or for dissemination in the United States MONTREAL, Nov. 29, 2024 (GLOBE NEWSWIRE) — SIRIOS RESOURCES SIRIOS INC. (TSX-V: SOI) (the “Corporation”) announces its intention to complete a non-brokered private placement with investors relying on a prospectus exemption pursuant to Regulation 45-106 respecting Prospectus Exemptions for gross proceeds of up to $2,000,000 (the “Units Offering”). This Offering will consist of the issuance of a maximum of 40,000,000 units of the Corporation (the “Units”) at a price of 0.05$ per Unit. Each Unit will consist of one common share of the capital of the Corporation (a “Common Share”) and one Common Share purchase warrant (a “Warrant”). Each Warrant entitles the holder thereof to purchase one Common Share at an exercise price of...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.